Endogenous Endophthalmitis (EE) is a rare cause of blindness in the pediatric age group and this may account for the paucity of management guidelines in the literature. In this report, we describe our experience with a 10-year-old immunocompetent female who developed EE and became blind because of rapidly progressive and destructive inflammatory changes in her eye in spite of seemingly timely treatment.
RachitskayaAVFlynnHWDavisJL.Endogenous endophthalmitis caused by salmonella serotype B in an immunocompetent 12-year-old child. Arch Ophthalmol2012; 130: 802–804.
Fernández-RubioME.Geographic location and endophthalmitis. Ophthalmology2012; 119: 2655–2656.e5.
13.
MalingSKingCDaviesN.A British ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye2018; 32: 743–748.
14.
WuZHYChanRPSLukFOJ, et al. Review of clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis over an 8-year period. J Ophthalmol2012; 2012: 265078.
15.
HsuLYWijayaLShu-TingNg E, et al. Tropical fungal infections. Infect Dis Clin North Am2012; 26: 497–512.
16.
TalleySMColeyPDKursarTA.The effects of weather on fungal abundance and richness among 25 communities in the Intermountain West. BMC Ecol2002; 2: 7.
17.
PriyamvadaHSinghRKAkilaM, et al. Seasonal variation of the dominant allergenic fungal aerosols – one year study from southern Indian region. Sci Rep2017; 7: 11171.
18.
GhoshAKGuptaARudramurthySM, et al. Fungal keratitis in north India: spectrum of agents, risk factors and treatment. Mycopathologia2016; 181: 843–850.
19.
BongominFGagoSOladeleRO, et al. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel)2017; 3: E57.
20.
FergusonBJ.Fungus balls of the paranasal sinuses. Otolaryngol Clin North Am2000; 33: 389–398.
21.
PourbaixALafont RapnouilBGuéryR, et al. Smoking as a risk factor of invasive fungal disease: systematic review and meta-analysis. Clin Infect Dis2020; 71: 1106–1119.
22.
SridharJFlynnHWKuriyanAE, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect2013; 3: 60.
23.
EssmanTFFlynnHWSmiddyWE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers1997; 28: 185–194.
24.
LingappanAWykoffCCAlbiniTA, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol2012; 153: 162–166.e1.
25.
TekaiaFLatgéJ-P.Aspergillus fumigatus: saprophyte or pathogen?Curr Opin Microbiol2005; 8: 385–392.
26.
GerginovaMManasievJYemendzhievH, et al. Biodeg-radation of phenol by Antarctic strains of Aspergillus fumigatus. Z Naturforsch C J Biosci2013; 68: 384–393.
27.
JagerMJChodoshJHuangAJ, et al. Aspergillus niger as an unusual cause of scleritis and endophthalmitis. Br J Ophthalmol1994; 78: 584–586.
28.
MankuHMcCluskeyP.Diagnostic vitreous biopsy in patients with uveitis: a useful investigation?Clin Exp Ophthalmol2005; 33: 604–610.
29.
BinderMIChuaJKaiserPK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine2003; 82: 97–105.
30.
RiddellJComerGMKauffmanCA.Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis2011; 52: 648–653.
31.
AbelADMeyerDR.Enucleation with primary implant insertion for treatment of recalcitrant endophthalmitis and panophthalmitis. Ophthal Plast Reconstr Surg2005; 21: 220–226.
32.
HuiJI.Outcomes of orbital implants after evisceration and enucleation in patients with endophthalmitis. Curr Opin Ophthalmol2010; 21: 375–379.
33.
MiglioriME.Enucleation versus evisceration. Curr Opin Ophthalmol2002; 13: 298–302.
34.
AbdinADSuffoSAlnaggarD, et al. Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab. Am J Ophthalmol Case Rep2020; 17: 100591.
35.
LyVSallamA.Fungal endophthalmitis [Internet]. In: StatPearls. Treasure Island, FL: StatPearls Publishing, http://www.ncbi.nlm.nih.gov/books/NBK559257/ (2020, accessed 22 January 2021).
LevyJZalkinderIKupermanO, et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol1995; 95: 806–812.
38.
PandyaDPuttannaABalagopalV.Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J2014; 8: 59–65.
39.
LeeCKlaustermeyerWB.Effect of high dose inhaled corticosteroids on cell mediated immunity in patients with asthma. Allergol Immunopathol2012; 40: 100–103.
